000			02130 a2200601 4500
005			20250514065645.0
264		0	_c20030627
008			200306s 0 0 eng d
022			_a1524-4563
024	7		_a10.1161/01.HYP.0000073782.30879.16 _2doi
040			_aNLM _beng _cNLM
100	1		_aKööbi, Peeter
245	0	0	_aAT1 receptor blockade improves vasorelaxation in experimental renal failure. _h[electronic resource]
260			_bHypertension (Dallas, Tex. : 1979) _cJun 2003
300			_a1364-71 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAngiotensin Receptor Antagonists
650	0	4	_aAnimals
650	0	4	_aAorta _xchemistry
650	0	4	_aAtrial Natriuretic Factor _xbiosynthesis
650	0	4	_aBlood Pressure
650	0	4	_aEndothelium, Vascular _xphysiology
650	0	4	_aHeart Ventricles _xmetabolism
650	0	4	_aIn Vitro Techniques
650	0	4	_aLosartan _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMesenteric Arteries _xdrug effects
650	0	4	_aNatriuretic Peptide, Brain _xbiosynthesis
650	0	4	_aNephrectomy
650	0	4	_aPeptidyl-Dipeptidase A _xanalysis
650	0	4	_aPotassium Channel Blockers _xpharmacology
650	0	4	_aPotassium Channels, Calcium-Activated _xantagonists & inhibitors
650	0	4	_aProtein Precursors _xblood
650	0	4	_aRNA, Messenger _xbiosynthesis
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptor, Angiotensin, Type 1
650	0	4	_aRenal Insufficiency _xdrug therapy
650	0	4	_aVasoconstriction
650	0	4	_aVasodilation _xdrug effects
700	1		_aKalliovalkama, Jarkko
700	1		_aJolma, Pasi
700	1		_aRysä, Jaana
700	1		_aRuskoaho, Heikki
700	1		_aVuolteenaho, Olli
700	1		_aKähönen, Mika
700	1		_aTikkanen, Ilkka
700	1		_aFan, Meng
700	1		_aYlitalo, Pauli
700	1		_aPörsti, Ilkka
773	0		_tHypertension (Dallas, Tex. : 1979) _gvol. 41 _gno. 6 _gp. 1364-71
856	4	0	_uhttps://doi.org/10.1161/01.HYP.0000073782.30879.16 _zAvailable from publisher's website
999			_c12531684 _d12531684